About the Company
The mission of Luminex is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. The Company offers a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. Luminex accelerates reliable answers while simplifying complexity and deliver certainty with a seamless experience.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $LMNX News
Miami University receives $1M gift for John W. Altman Institute for Entrepreneurship
I am honored to give this gift to the Institute for Entrepreneurship, named for my uncle, with whom I share both love for ...
Global Pancreatic Elastase Testing Market is expected to reach US$ 36.2 Million by 2033
Pancreatic Elastase Testing Market is anticipated to grow to US$ 36.2 Million by 2033 to increase at a CAGR of nearly 8.1%.
Closing Bell: Luminex Resources Corp down on Monday (LR)
In today's trading, shares of Luminex Resources Corp opened at $0.17 and closed at $0.17. Intraday prices ranged from $0.17 to $0.17. Share prices dipped -2.78 percent from the previous day's close of ...
Aspira Women’s Health Expands Senior Leadership Team with the Addition of Sandra Milligan, M.D., J.D. as President
Dr. Pappas first joined Aspira in 2013 and has experience in R&D, commercial, and clinical operations at Aspira, Delphi, Inc., Reliant Immune Diagnostics, and Luminex Corporation. His work has been ...
Adventus Mining Announces the Signing of an Investment Agreement with the Government of Ecuador for the Development of the Condor Project
CNW/ - Adventus Mining Corporation ("Adventus" or the "Company") (TSXV: ADZN) (OTCQX: ADVZF) is pleased to announce the ...
Anti-microbial/Anti-fungal Tests Market Ascending with a 5.7% CAGR by 2032
Worldwide, fungal and microbial diseases are a major cause of mortality and have the capacity to spread like epidemics, which ...
Ecuador government inks investment agreements with Adventus, Atico
The project was acquired by Adventus through its recent merger with Luminex Resources (TSXV ... signifies the confluence of ...
Genetic Testing Market Size, Share And Growth Report 2024-2032
IMARC Group, a leading market research company, has recently releases report titled“ Genetic Testing Market Report by Type (Predictive and Presymptomatic Testing, Carrier Testing, Prenatal and Newborn ...
Cytek Biosciences, Inc.: Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
Cytek® Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results ...
Influenza Diagnostics Market Share Estimated to Reach USD 1.46 Billion By 2032, at 7.1% CAGR Growth: Polaris Market Research
New York, NY, March 08, 2024 (GLOBE NEWSWIRE) -- The latest research report [115+] pages with 360-degree visibility, titled ...
Flow Cytometry Market Outlook, Top Industry Trends To 2031
(MENAFN- Straits Research) Cytometry employs a wide variety of cutting-edge techniques, the majority of which evaluate the molecular characteristics of cells by using fluorescent labeling to detect ...
Loading the latest forecasts...